Literature DB >> 33738565

Non-aesthetic uses of botulinum toxin in the head and neck.

Natalie Anne Watson1, Zohaib Siddiqui2, Benjamin John Miller3, Yakubu Karagama3, Nicholas Gibbins2.   

Abstract

INTRODUCTION: The use of botulinum toxin in the specialty of aesthetic surgery in the head and neck is well known. However, it has also been used for other conditions affecting the head and neck, and in recent years its use, as well as the number of relevant applications, has expanded enormously. REVIEW: This article presents a summary of the current range of uses in the laryngeal, pharyngeal, cervical, oromandibular and facial muscles and salivary glands. We highlight particular conditions focusing on dystonia (laryngeal, craniocervical, oromandibular and cervical), multiple system atrophy, migraines, facial nerve palsy, post-laryngectomy, cricopharyngeal dysphagia, Zenker's diverticulum, retrograde cricopharyngeal dysfunction disorder, sialorrhea and gustatory sweating (Frey's syndrome).
CONCLUSION: This article should aid the ear, nose and throat surgeon garner knowledge about the range of uses for botulinum toxin in the head and neck.

Entities:  

Keywords:  Botulinum toxin injection; Cricopharyngeal dysphagia; Dystonia; Migraine; Spasmodic dysphonia

Year:  2021        PMID: 33738565     DOI: 10.1007/s00405-021-06750-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 2.  Multiple-system atrophy.

Authors:  Alessandra Fanciulli; Gregor K Wenning
Journal:  N Engl J Med       Date:  2015-01-15       Impact factor: 91.245

3.  Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy.

Authors:  D Dressler
Journal:  Eur J Neurol       Date:  2000-11       Impact factor: 6.089

Review 4.  Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Authors:  Gonçalo S Duarte; Mafalda Castelão; Filipe B Rodrigues; Raquel E Marques; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-26

Review 5.  Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.

Authors:  Babette F van Esch; Inge Wegner; Inge Stegeman; Wilko Grolman
Journal:  Otolaryngol Head Neck Surg       Date:  2016-11-01       Impact factor: 3.497

Review 6.  Systematic review of botulinum toxin treatment for oromandibular dystonia.

Authors:  Cynthia L Comella
Journal:  Toxicon       Date:  2018-02-14       Impact factor: 3.033

Review 7.  Research priorities in spasmodic dysphonia.

Authors:  Christy L Ludlow; Charles H Adler; Gerald S Berke; Steven A Bielamowicz; Andrew Blitzer; Susan B Bressman; Mark Hallett; H A Jinnah; Uwe Juergens; Sandra B Martin; Joel S Perlmutter; Christine Sapienza; Andrew Singleton; Caroline M Tanner; Gayle E Woodson
Journal:  Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 3.497

8.  Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Authors:  A Blitzer; M F Brin; C F Stewart
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

9.  Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.

Authors:  Osama H Ababneh; Altug Cetinkaya; Dwight R Kulwin
Journal:  Clin Exp Ophthalmol       Date:  2013-08-04       Impact factor: 4.207

Review 10.  Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.

Authors:  Carlos Henrique Ferreira Camargo; Lígia Cattai; Hélio Afonso Ghizoni Teive
Journal:  Toxins (Basel)       Date:  2015-06-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.